Published in J Nat Prod on June 18, 2008
Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Curr Mol Med (2011) 1.15
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J Nat Prod (2009) 0.97
Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives. Bioorg Med Chem (2012) 0.87
Mangosteen pericarp extract inhibits the formation of pentosidine and ameliorates skin elasticity. J Clin Biochem Nutr (2015) 0.84
Natural products as aromatase inhibitors. Anticancer Agents Med Chem (2008) 0.82
Natural compounds with aromatase inhibitory activity: an update. Planta Med (2010) 0.81
Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer. Front Pharmacol (2013) 0.78
Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients (2017) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol (2003) 1.77
Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res (2003) 1.73
Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A (2005) 1.67
Xanthone derivatives: new insights in biological activities. Curr Med Chem (2005) 1.55
Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem (2006) 1.54
Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol (2004) 1.45
Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab (2002) 1.39
Purification and characterization of human placental aromatase cytochrome P-450. J Biol Chem (1987) 1.25
Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res (2001) 1.25
Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J Clin Endocrinol Metab (2003) 1.12
Update on the use of aromatase inhibitors in breast cancer. Expert Opin Pharmacother (2006) 1.12
Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J Nat Prod (2003) 1.11
Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res (2006) 1.09
Aromatase and cyclooxygenases: enzymes in breast cancer. J Steroid Biochem Mol Biol (2003) 1.07
Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer. J Steroid Biochem Mol Biol (2005) 0.99
White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr (2001) 0.98
Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci (2004) 0.94
Estrogens, brain and behavior: studies in fundamental neurobiology and observations related to women's health. J Steroid Biochem Mol Biol (2000) 0.93
Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay. Biotechniques (1994) 0.92
Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells. J Med Chem (2007) 0.90
Estrogens and women's health: interrelation of coronary heart disease, breast cancer and osteoporosis. J Steroid Biochem Mol Biol (2000) 0.89
The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reprod Nutr Dev (2005) 0.88
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay. J Nat Prod (2006) 0.88
Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women. Breast (2005) 0.87
A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. J Med Chem (2001) 0.84
Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use. Clin Breast Cancer (2006) 0.82
Dietary phytoestrogens: potential selective estrogen enzyme modulators? Planta Med (2005) 0.82
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. J Med Chem (1995) 0.78
Novel concepts for the chemoprevention of breast cancer through aromatase inhibition. Endocr Relat Cancer (2006) 0.78
Management of bone loss induced by aromatase inhibitors. Cancer Invest (2006) 0.78
Drug discovery from medicinal plants. Life Sci (2005) 4.26
Drug discovery from natural sources. AAPS J (2006) 2.76
Gamma-secretase gene mutations in familial acne inversa. Science (2010) 2.30
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood (2009) 1.83
Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anticancer Agents Med Chem (2006) 1.76
New chemical constituents of Euphorbia quinquecostata and absolute configuration assignment by a convenient Mosher ester procedure carried out in NMR tubes. J Nat Prod (2002) 1.74
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem (2004) 1.69
Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab (2005) 1.56
Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem (2006) 1.54
Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes. J Nat Prod (2009) 1.48
Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites. Mol Nutr Food Res (2012) 1.48
Reconsidering the length of program accreditation. Am J Pharm Educ (2011) 1.44
Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod (2002) 1.39
Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res (2006) 1.26
New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. PLoS One (2013) 1.24
Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res (2007) 1.23
Bioactive constituents of the stem bark of Mitrephora glabra. J Nat Prod (2009) 1.23
Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata. J Nat Prod (2010) 1.23
The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target (2009) 1.20
Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition. J Med Chem (2006) 1.19
HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients. PLoS One (2013) 1.16
Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis (2003) 1.16
Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol Cancer Ther (2008) 1.15
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol Pharmacol (2005) 1.13
Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J Clin Endocrinol Metab (2003) 1.12
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Mol Pharmacol (2006) 1.12
Virologic outcomes of first-line HAART and associated factors among Chinese patients with HIV in three sentinel antiretroviral treatment sites. Trop Med Int Health (2010) 1.12
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum. J Nat Prod (2008) 1.12
Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. AIDS (2013) 1.11
Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents. ACS Med Chem Lett (2012) 1.11
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells. AAPS J (2011) 1.11
Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism. Nutr Cancer (2009) 1.10
Activity-guided isolation of cytotoxic constituents from the bark of Aglaia crassinervia collected in Indonesia. Bioorg Med Chem (2005) 1.09
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. J Nat Prod (2009) 1.09
The final catalytic step of cytochrome p450 aromatase: a density functional theory study. J Am Chem Soc (2005) 1.08
Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem (2007) 1.08
Aptamer-mediated efficient capture and release of T lymphocytes on nanostructured surfaces. Adv Mater (2011) 1.07
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia. J Nat Prod (2004) 1.06
Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron (2012) 1.05
Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J Steroid Biochem Mol Biol (2002) 1.05
Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol. Clin Cancer Res (2012) 1.04
An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni). J Nat Prod (2005) 1.04
Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Curr Drug Targets (2010) 1.02
Structural Characterization, Biological Effects, and Synthetic Studies on Xanthones from Mangosteen (Garcinia mangostana), a Popular Botanical Dietary Supplement. Mini Rev Org Chem (2008) 1.01
Highly sweet compounds of plant origin. Arch Pharm Res (2002) 1.00
Are we producing innovators and leaders or change resisters and followers? Am J Pharm Educ (2012) 1.00
Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo. J Nat Prod (2003) 1.00
Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats. Pharm Res (2010) 1.00
Bioactive constituents of Indigofera spicata. J Nat Prod (2013) 1.00
Lignans and other constituents of the fruits of Euterpe oleracea (Acai) with antioxidant and cytoprotective activities. J Agric Food Chem (2008) 0.99
Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist (2008) 0.99
Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer. Anticancer Agents Med Chem (2006) 0.99
Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam. Bioorg Med Chem (2008) 0.99
Constituents of the Leaves and Stem Bark of Aglaia foveolata. Tetrahedron (2007) 0.98
Prenylated flavonoids of the leaves of Macaranga conifera with inhibitory activity against cyclooxygenase-2. Phytochemistry (2002) 0.98
Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res (2010) 0.98
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int J Pharm (2010) 0.97
Bioactive constituents of the seeds of Brucea javanica. Planta Med (2002) 0.97
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J Nat Prod (2009) 0.97
Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J Nutr (2012) 0.97
The role of pharmacognosy in modern medicine and pharmacy. Curr Drug Targets (2006) 0.97
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol (2013) 0.96
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41. MAbs (2009) 0.95
Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment. PLoS One (2013) 0.95
Chemopreventive characteristics of avocado fruit. Semin Cancer Biol (2007) 0.95
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species. Nat Prod Rep (2014) 0.95
Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J Nat Prod (2005) 0.95
Hydrophobic interaction-mediated capture and release of cancer cells on thermoresponsive nanostructured surfaces. Adv Mater (2012) 0.95
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometry. AAPS J (2011) 0.95
Aromatase and COX in breast cancer: enzyme inhibitors and beyond. J Steroid Biochem Mol Biol (2007) 0.94
Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen). Phytochemistry (2007) 0.94
The continuing search for antitumor agents from higher plants. Phytochem Lett (2010) 0.94
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa. J Nat Prod (2004) 0.94
Antimicrobial constituents from goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Med (2003) 0.94
Identification of a class of novel tubulin inhibitors. J Med Chem (2012) 0.94
Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer. PLoS One (2013) 0.93
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru. J Nat Prod (2004) 0.93
A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms. Biochem Pharmacol (2009) 0.93
Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents from Eleaocarpus chinensis. J Nat Prod (2012) 0.93
Synthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer. J Comb Chem (2008) 0.93
Interfacial material system exhibiting superwettability. Adv Mater (2014) 0.93
Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells. Anticancer Res (2006) 0.93
DNA-based intelligent logic controlled release systems. Chem Commun (Camb) (2012) 0.93
Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer. Cancer Res (2011) 0.92
Pervilleines B and C, new tropane alkaloid aromatic esters that reverse the multidrug-resistance in the hollow fiber assay. Cancer Lett (2002) 0.92
Tropane aromatic ester alkaloids from a large-scale re-collection of Erythroxylum pervillei stem bark obtained in Madagascar. J Nat Prod (2006) 0.92
A hexacyclic ent-trachylobane diterpenoid possessing an oxetane ring from Mitrephora glabra. Org Lett (2005) 0.92
An ion-induced low-oil-adhesion organic/inorganic hybrid film for stable superoleophobicity in seawater. Adv Mater (2012) 0.91
Isolation and absolute stereochemistry of coussaric acid, a new bioactive triterpenoid from the stems of Coussarea brevicaulis. Phytochemistry (2003) 0.91
Antioxidant and cytoprotective compounds from Berberis vulgaris (barberry). Phytother Res (2008) 0.91
Novel bioactive clerodane diterpenoids from the leaves and twigs of Casearia sylvestris. J Nat Prod (2002) 0.91
[Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence]. Zhonghua Yi Xue Za Zhi (2004) 0.91
Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells. J Med Chem (2007) 0.90
Bioactive flavaglines and other constituents isolated from Aglaia perviridis. J Nat Prod (2013) 0.90
Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean). J Nat Prod (2003) 0.90
Relationships between inhibitory activity against a cancer cell line panel, profiles of plants collected, and compound classes isolated in an anticancer drug discovery project. Chem Biodivers (2006) 0.90
Cytotoxic flavaglines and bisamides from Aglaia edulis. J Nat Prod (2006) 0.90
Apoptotic anticancer effect of alvaradoin E isolated from Alvaradoa haitiensis. Anticancer Res (2005) 0.90
Merocyclophanes A and B, antiproliferative cyclophanes from the cultured terrestrial Cyanobacterium Nostoc sp. Phytochemistry (2012) 0.90
Potential cancer chemopreventive constituents of the leaves of Macaranga triloba. Phytochemistry (2004) 0.90